A peer-level look at how ophthalmologists and cataract surgeons weigh surgical waste, reusable instrumentation, sterility, regulation, manufacturer responsibility, and the practical readiness of cataract pathways to become more sustainable.
Audience: Ophthalmologists / Cataract Surgeons
Countries: 6
Completion Rate: 81.5%
SGID: 8935144
-Hero findings
– Quick Read — Key Findings
That combination makes small workflow choices matter. A drape, pack insert, bottle, tubing set, or unused item may appear trivial in one case and become material when multiplied across a high-volume cataract service.
EyeSustain and ophthalmic societies increasingly treat operating-room waste as a specialty systems issue, emphasizing regular review of cataract packs, appropriate multidose topical use where permitted, reassessment of reusable versus single-use instrumentation, specialty sterilization guidance, recycling, and collaboration with manufacturers and regulators. The MDForLives survey asks where the real friction sits, and the answers suggest willingness is not the missing ingredient: surgeons point to regulation, infection-control concerns, product design, pack configuration, and the absence of globally accepted reuse pathways as the places where sustainable intent meets operational limits.
31.9% describe environmental sustainability as very important in cataract decisions, while 45.5% describe their primary facility as only moderately prepared for eco-conscious ophthalmic innovations.
Importance is not dominated by indifference: very important is the largest category at 31.9%, followed by moderately important at 27.7% and extremely important at 21.3%, with only 6.4% saying it does not matter, so more than 80% rate sustainability at least moderately important and what lags is capacity, not interest. Readiness is more cautious, with moderately prepared the largest category at 45.5% versus 27.3% very and 6.8% extremely prepared, a gap that matters because these decisions are rarely the surgeon’s alone: procurement contracts, sterile processing, infection-control policy, manufacturer labeling, accreditation, and regulatory interpretation all shape what is operationally possible.
39.1% say reprocessing or sterilizing eligible reusable instruments is the single most significant sustainability practice their team has integrated.
Reprocessing leads the implemented practices at 39.1%, ahead of streamlined packs at 21.7%, drug-protocol reform at 13.0%, waste segregation and recycling at 8.7%, and fully digital workflows at 4.3%, while 13.0% have no formal practice yet, so reuse is not hypothetical, the question is less whether to reuse than how to extend it safely. Asked about future transition under an explicit condition of equivalent safety, sterility, and visual outcomes, 47.7% support reuse and another 38.6% strongly support it, and while those figures should be read separately rather than combined, together they show reuse becomes acceptable once it is framed as outcome-neutral and safety-equivalent.
35.6% identify disposable surgical packs and drapes as the largest source of unnecessary waste, followed by single-use plastic consumables at 31.1%.
The two leaders sit well ahead of over-packaged sterile supplies and manufacturer boxes at 17.8%, with partial-use pharmaceuticals at 8.9%, disposable PPE at 4.4%, and paper or sterilization wraps at 2.2%, so packs, drapes, and single-use plastics together make up about two-thirds of the perceived waste, a diagnosis that lines up with Finding 5, where the most-wanted industry actions are also packaging reduction and lean packs. This tracks current EyeSustain and ESCRS work on pack standardization, including the SIDICS tool for evaluating customized cataract packs, and confirms surgeons see pack design not as peripheral but as one of the most visible sources of avoidable material.
33.3% identify rigid national or institutional regulatory requirements prohibiting reusable items as the single greatest barrier to more sustainable cataract protocols.
Infection-control and patient-safety concerns rank second at 22.2%, followed by cost or weak incentives at 17.8%, limited institutional leadership at 13.3%, a shortage of validated reusable devices at 8.9%, and thin standardized guidance at 4.4%. Read together, safety and regulatory concerns account for 55.5% of the top-barrier votes, well ahead of cost or missing hardware, so the binding constraint is permission and governance, which is why Finding 6 puts evidence-based reuse guidance at the top of the wish list. Ophthalmic societies have already issued sterilization guidance and a 2026 multisociety position paper asking industry and regulators to expand validated multiuse options, yet local labeling, national rules, accreditation, and liability still shape what a surgeon can actually do.
34.1% choose a significant reduction in plastic packaging and paper inserts, compared with 29.5% who choose standardized lean custom packs.
Validated reusable phacoemulsification handpieces are chosen by 18.2%, manufacturer recycling and take-back by 13.6%, and multi-use topical drops by 4.5%, so the two front-runners, less packaging and lean packs, together take about 64% and are both upstream changes industry can make without new device validation, while the option that does require validation, reusable phaco at 18.2%, sits lower, fitting Finding 4: surgeons favor the reductions today’s rules already allow. Packaging is especially actionable because it changes upstream, and multisociety efforts have already called for electronic instructions for use where permitted, so surgeons see manufacturers as able to remove waste before it enters the OR.
54.5% say evidence-based global guidelines for safe reuse of selected consumables would most effectively reduce cataract surgery’s environmental footprint.
Eco-designed consumables from biodegradable or recycled materials rank second at 29.5% and carbon-auditing tools at 15.9%, while primary leadership splits evenly, professional societies and manufacturers tied at 34.1% each. Global reuse guidance at 54.5% outweighs the other two levers combined, so surgeons are asking first for permission and standards rather than new materials or measurement tools, and because leadership is shared, neither party is expected to move alone: societies define evidence-based standards while manufacturers control product design, packaging, instructions for use, validated reuse options, and supply choices, with regulators, facilities, and procurement determining whether those options can be implemented safely and consistently.
The survey shows a specialty that is not waiting to be convinced that waste matters. Sustainability is important to many respondents, reprocessing is already the leading implemented practice, and support for reusable instruments rises sharply when safety and outcomes are explicitly protected, yet facilities remain only moderately prepared, regulation is the leading barrier, and surgeons want stronger evidence-based reuse guidance.
The open-ended responses make the tension concrete: surgeons ask for reusable, easily sterilized instruments, less single-use material, better pack standardization, evidence-based safety, clearer regulations, manufacturer changes, organizational leadership, and protection from added liability. They are not asking for permission to be less safe, but for a pathway that makes the lower-waste choice clinically and legally defensible.
You have read the summary
Common questions about surgical waste, reusable instruments, multidose medications, cataract packs, and leadership for sustainable ophthalmic care.
Direct answers to the questions healthcare professionals are most likely to ask about these findings.
